Confirm delete?

Bertin Bioreagent


Contact Us

JWH 122

  • Zoom
    JWH 122
  • JWH 122
Cat No: 10591
Chemicals - Forensic Regulated
Price is excluding VAT and does not include packaging neither shipping

A CB that displays high-affinities for both CB1 (Ki = 0.69 nM) and CB2 (Ki = 1.2 nM) receptors
JWH 122 is a synthetic cannabinoid (CB) that displays high-affinities for both CB1 (Ki = 0.69 nM) and CB2 (Ki = 1.2 nM) receptors.


This article is not for sale online.
Contact us for more information about this article.

FREE Squish Fish

Squish Fish Bertin Pharma

1 purchase = 1 FREE Squish Fish
For the summer, Bertin Bioreagent includes one free Squish Fish for each order!
When ordering your kits, add the promo code BLS2018 to get a free Squish Fish.

Buying online?
No promo code needed!
Your special offer applies automatically.
Limited offer, from July 2nd to August 31st, while stocks last.


Territorial Availability: Specific regulation - Please contact Bertin Technologies Customer Service
Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substances laboratories and qualified academic research institutions. Please consult our General Terms and conditions of Sales.
Special Advice: regulated item by French and American Administrations DEA + ANSM / special delivery time and additional fees.
Product Overview:
A CB that displays high-affinities for both CB1 (Ki = 0.69 nM) and CB2 (Ki = 1.2 nM) receptors
JWH 122 is a synthetic cannabinoid (CB) that displays high-affinities for both CB1 (Ki = 0.69 nM) and CB2 (Ki = 1.2 nM) receptors.
Size: 10 mg
Shipping: wet ice
Stability: Store at -20 degrees; shelf life 365 days maximum after production
CAS Number: 619294-47-2
Molecular Formula: C25H25NO
Molecular Weight: 355.5
Formulation: A crystalline solid
Purity: ≥98%
Custom Code: 2933497050
UNSPSC code: 12352100

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : JWH 122 There are 10 products.